Absci to Participate in the Morgan Stanley 2nd Annual Biotechnology AI Summit
ABSI Stock | USD 3.68 0.70 15.98% |
Under 67% of Absci Corp's investor base is looking to short. The analysis of the overall investor sentiment regarding Absci Corp suggests that many traders are alarmed. Absci Corp's investing sentiment shows overall attitude of investors towards Absci Corp.
Absci |
VANCOUVER, Wash. and NEW YORK, June 15, 2023 Absci Corporation , a generative AI drug creation company, today announced the company will be participating in the upcoming Morgan Stanley 2nd Annual Biotechnology AI Summit in New York, NY. Absci management is scheduled to participate in a panel discussion on Thursday June 29th. Interested parties may contact their Morgan Stanley representative to request registration details for this live event. About Absci Absci i
Read at finance.yahoo.com
Absci Corp Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Absci Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Absci Corp Fundamental Analysis
We analyze Absci Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Absci Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Absci Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Retained Earnings
Retained Earnings Comparative Analysis
Absci Corp is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
Absci Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Absci Corp stock to make a market-neutral strategy. Peer analysis of Absci Corp could also be used in its relative valuation, which is a method of valuing Absci Corp by comparing valuation metrics with similar companies.
Peers
Absci Corp Related Equities
XFOR | X4 Pharmaceuticals | 16.58 | ||||
INZY | Inozyme Pharma | 0.67 | ||||
HEPA | Hepion Pharmaceuticals | 0.16 | ||||
RXRX | Recursion Pharmaceuticals | 1.72 | ||||
DAWN | Day One | 2.89 | ||||
AFMD | Affimed NV | 3.54 | ||||
CRBU | Caribou Biosciences | 3.96 | ||||
RLAY | Relay Therapeutics | 4.02 | ||||
ELEV | Elevation Oncology | 4.42 | ||||
DTIL | Precision BioSciences | 5.56 | ||||
ABOS | Acumen Pharmaceuticals | 7.34 | ||||
ZURA | Zura Bio | 12.35 | ||||
SANA | Sana Biotechnology | 12.82 |
Complementary Tools for Absci Stock analysis
When running Absci Corp's price analysis, check to measure Absci Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Absci Corp is operating at the current time. Most of Absci Corp's value examination focuses on studying past and present price action to predict the probability of Absci Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Absci Corp's price. Additionally, you may evaluate how the addition of Absci Corp to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |